<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00795249</url>
  </required_header>
  <id_info>
    <org_study_id>KurumeU-08061</org_study_id>
    <nct_id>NCT00795249</nct_id>
  </id_info>
  <brief_title>Effects of Chronic Smoking on Circulating Endothelial and Platelet-derived Microparticle</brief_title>
  <official_title>Effects of Chronic Smoking on Circulating Endothelial and Platelet-derived Microparticle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kurume University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kurume University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesized that circulating EMP is a useful surrogate marker of early
      stage of endothelial damage. To determine the effects of chronic smoking on circulating EMP,
      from healthy volunteers who have habit of chronic smoking, peripheral blood is drawn at the
      time of flow-mediated dilatation (FMD) examination. Spot urine is also collected. Circulating
      EMPs are counted using flow-cytometry. After 2-week smoking cessation, the measurements were
      repeated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of circulating EMP</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>FMD</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>smoker</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals who have a habit of chronic smoking without any coronary risk factors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-smoker</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>the age-matched healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>smoking cessation</intervention_name>
    <description>After baseline examination, the group is asked to quit smoking for 2 weeks.</description>
    <arm_group_label>smoker</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy individuals who have no coronary risk factors

        Exclusion Criteria:

          -  hypertension

          -  dyslipidemia

          -  chronic kidney disease

          -  liver dysfunction

          -  obesity (BMI&gt;25.0)

          -  cerebrovascular disease

          -  other severe systemic diseases (cancer, inflammatory diseases, etc)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tsutomu Imaizumi, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Kurume University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kurume University Hospital</name>
      <address>
        <city>Kurume</city>
        <state>Fukuoka</state>
        <zip>830-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2008</study_first_submitted>
  <study_first_submitted_qc>November 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2008</study_first_posted>
  <last_update_submitted>June 22, 2011</last_update_submitted>
  <last_update_submitted_qc>June 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Tsutomu Imaizumi/Chair of Cardio-vascular Medicine Kurume University</name_title>
    <organization>Cardio-vascular Medicine Kurume University</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

